Literature DB >> 23337120

In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery.

K T Smitha1, A Anitha, T Furuike, H Tamura, Shantikumar V Nair, R Jayakumar.   

Abstract

Chitin and its derivatives have been widely used in drug delivery applications due to its biocompatible, biodegradable and non-toxic nature. In this study, we have developed amorphous chitin nanoparticles (150±50 nm) and evaluated its potential as a drug delivery system. Paclitaxel (PTX), a major chemotherapeutic agent was loaded into amorphous chitin nanoparticles (AC NPs) through ionic cross-linking reaction using TPP. The prepared PTX loaded AC NPs had an average diameter of 200±50 nm. Physico-chemical characterization of the prepared nanoparticles was carried out. These nanoparticles were proven to be hemocompatible and in vitro drug release studies showed a sustained release of PTX. Cellular internalization of the NPs was confirmed by fluorescent microscopy as well as by flow cytometry. Anticancer activity studies proved the toxicity of PTX-AC NPs toward colon cancer cells. These preliminary results indicate the potential of PTX-AC NPs in colon cancer drug delivery.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23337120     DOI: 10.1016/j.colsurfb.2012.11.031

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  9 in total

1.  Fabrication of magnetic and fluorescent chitin and dibutyrylchitin sub-micron particles by oil-in-water emulsification.

Authors:  Barbara Blanco-Fernandez; Shatadru Chakravarty; Michael K Nkansah; Erik M Shapiro
Journal:  Acta Biomater       Date:  2016-09-01       Impact factor: 8.947

Review 2.  Insight to drug delivery aspects for colorectal cancer.

Authors:  Arvind Gulbake; Aviral Jain; Ashish Jain; Ankit Jain; Sanjay K Jain
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

3.  Wheat Germ Agglutinin-Conjugated Disulfide Cross-Linked Alginate Nanoparticles as a Docetaxel Carrier for Colon Cancer Therapy.

Authors:  Hock Ing Chiu; Vuanghao Lim
Journal:  Int J Nanomedicine       Date:  2021-04-22

4.  Sustainable ecofriendly phytoextract mediated one pot green recovery of chitosan.

Authors:  Judy Gopal; Manikandan Muthu; Thirumalai Dhakshanamurthy; Ki Jun Kim; Nazim Hasan; Seong Jung Kwon; Sechul Chun
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

5.  Antitumor Effects of N-Butylidenephthalide Encapsulated in Lipopolyplexs in Colorectal Cancer Cells.

Authors:  Kai-Fu Chang; Jinghua Tsai Chang; Xiao-Fan Huang; Yu-Ling Lin; Kuang-Wen Liao; Chien-Wei Huang; Nu-Man Tsai
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

Review 6.  Advances in Bio-Based Polymers for Colorectal CancerTreatment: Hydrogels and Nanoplatforms.

Authors:  Anna Maspes; Fabio Pizzetti; Arianna Rossetti; Pooyan Makvandi; Giovanni Sitia; Filippo Rossi
Journal:  Gels       Date:  2021-01-11

7.  Injectable Amorphous Chitin-Agarose Composite Hydrogels for Biomedical Applications.

Authors:  Murali Vishnu Priya; Rajendran Arun Kumar; Amirthalingam Sivashanmugam; Shantikumar Vasudevan Nair; Rangasamy Jayakumar
Journal:  J Funct Biomater       Date:  2015-08-25

8.  Fabrication, Characterization, and Evaluation of Bionanocomposites Based on Natural Polymers and Antibiotics for Wound Healing Applications.

Authors:  Marius Rădulescu; Alina Maria Holban; Laurențiu Mogoantă; Tudor-Adrian Bălşeanu; George Dan Mogoșanu; Diana Savu; Roxana Cristina Popescu; Oana Fufă; Alexandru Mihai Grumezescu; Eugenia Bezirtzoglou; Veronica Lazar; Mariana Carmen Chifiriuc
Journal:  Molecules       Date:  2016-06-10       Impact factor: 4.411

9.  Docetaxel-Loaded Disulfide Cross-Linked Nanoparticles Derived from Thiolated Sodium Alginate for Colon Cancer Drug Delivery.

Authors:  Hock Ing Chiu; Asila Dinie Ayub; Siti Nur Aishah Mat Yusuf; Noorfatimah Yahaya; Erazuliana Abbd Kadir; Vuanghao Lim
Journal:  Pharmaceutics       Date:  2020-01-02       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.